MX2012001004A - Proceso para la obtencion de miofibroblastos. - Google Patents
Proceso para la obtencion de miofibroblastos.Info
- Publication number
- MX2012001004A MX2012001004A MX2012001004A MX2012001004A MX2012001004A MX 2012001004 A MX2012001004 A MX 2012001004A MX 2012001004 A MX2012001004 A MX 2012001004A MX 2012001004 A MX2012001004 A MX 2012001004A MX 2012001004 A MX2012001004 A MX 2012001004A
- Authority
- MX
- Mexico
- Prior art keywords
- identification
- myofibroblasts
- cells
- myofibroblast
- population
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a un proceso para la obtención de miofibroblastos. De conformidad con este proceso: (a) se prepara una muestra de células que comprende esencialmente fibroblastos; y (b) esta muestra de células se cultiva en un medio de cultivo libre de suero. El propósito principal atendido por la invención es obtener una población de miofibroblastos, las características de la cual facilitan cualquier estudio de estas células, y en particular tan pura como sea posible una población de miofibroblastos. Algunos ejemplos de aplicación de la invención son: identificación de biomarcadores de miofibroblastos, identificación de objetivos terapéuticos, identificación y validación de compuestos anticancerígenos, y un modelo in vitro para selección de compuestos farmacéuticos o cosméticos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0955216A FR2948381B1 (fr) | 2009-07-24 | 2009-07-24 | Procede d'obtention de myofibroblastes. |
PCT/EP2010/059478 WO2011009706A1 (fr) | 2009-07-24 | 2010-07-02 | Procede d'obtention de myofibroblastes |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012001004A true MX2012001004A (es) | 2012-05-29 |
Family
ID=41460947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012001004A MX2012001004A (es) | 2009-07-24 | 2010-07-02 | Proceso para la obtencion de miofibroblastos. |
Country Status (12)
Country | Link |
---|---|
US (1) | US9243228B2 (es) |
EP (1) | EP2456854B1 (es) |
JP (1) | JP5758891B2 (es) |
CN (1) | CN102471761A (es) |
AU (1) | AU2010275678B2 (es) |
CA (1) | CA2767929A1 (es) |
ES (1) | ES2650664T3 (es) |
FR (1) | FR2948381B1 (es) |
IL (1) | IL217352A (es) |
MX (1) | MX2012001004A (es) |
NZ (1) | NZ597728A (es) |
WO (1) | WO2011009706A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104096265B (zh) * | 2014-07-01 | 2016-03-23 | 温州医科大学 | 一种用于构建人工血管模型的三维收缩模型的制备方法 |
CN104630134A (zh) * | 2015-02-15 | 2015-05-20 | 叶中华 | 阴道上皮细胞培养基及阴道上皮细胞培养方法 |
CN111500527A (zh) * | 2020-06-30 | 2020-08-07 | 北京昱龙盛世生物科技有限公司 | 一种表皮干细胞的分离培养方法 |
IL311054A (en) * | 2021-09-07 | 2024-04-01 | Wisconsin Alumni Res Found | Extracellular matrix derived from cardiac fibroblast |
CN115197892A (zh) * | 2022-06-13 | 2022-10-18 | 浙江省人民医院 | 一种人甲状腺乳头状癌组织中成纤维细胞的分离培养方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5573937A (en) * | 1989-12-07 | 1996-11-12 | Snow Brand Milk Products Co., Ltd. | Serum free culture medium |
EP1715033A4 (en) * | 2004-02-13 | 2008-06-11 | Asahi Techno Glass Corp | MEANS FOR PREPARING NOURISHED CELLS FOR EMBRYONIC STEM CELLS AND NOURISHED CELLS |
EP1851305B1 (en) * | 2005-02-11 | 2012-01-18 | Novo Nordisk Health Care AG | Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate |
-
2009
- 2009-07-24 FR FR0955216A patent/FR2948381B1/fr active Active
-
2010
- 2010-07-02 NZ NZ597728A patent/NZ597728A/xx not_active IP Right Cessation
- 2010-07-02 US US13/386,522 patent/US9243228B2/en not_active Expired - Fee Related
- 2010-07-02 CA CA2767929A patent/CA2767929A1/fr not_active Abandoned
- 2010-07-02 CN CN2010800324369A patent/CN102471761A/zh active Pending
- 2010-07-02 ES ES10726999.5T patent/ES2650664T3/es active Active
- 2010-07-02 EP EP10726999.5A patent/EP2456854B1/fr not_active Not-in-force
- 2010-07-02 AU AU2010275678A patent/AU2010275678B2/en not_active Ceased
- 2010-07-02 WO PCT/EP2010/059478 patent/WO2011009706A1/fr active Application Filing
- 2010-07-02 MX MX2012001004A patent/MX2012001004A/es active IP Right Grant
- 2010-07-02 JP JP2012520985A patent/JP5758891B2/ja not_active Expired - Fee Related
-
2012
- 2012-01-03 IL IL217352A patent/IL217352A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2011009706A1 (fr) | 2011-01-27 |
ES2650664T3 (es) | 2018-01-19 |
FR2948381B1 (fr) | 2013-07-12 |
IL217352A0 (en) | 2012-02-29 |
NZ597728A (en) | 2013-11-29 |
US20120190109A1 (en) | 2012-07-26 |
CA2767929A1 (fr) | 2011-01-27 |
CN102471761A (zh) | 2012-05-23 |
JP5758891B2 (ja) | 2015-08-05 |
EP2456854B1 (fr) | 2017-08-30 |
AU2010275678A1 (en) | 2012-02-09 |
JP2013500003A (ja) | 2013-01-07 |
FR2948381A1 (fr) | 2011-01-28 |
IL217352A (en) | 2016-03-31 |
AU2010275678B2 (en) | 2016-06-16 |
EP2456854A1 (fr) | 2012-05-30 |
US9243228B2 (en) | 2016-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX356756B (es) | Células madre pluripotentes en microportadores. | |
WO2010096588A3 (en) | Cell culture media containing combinations of proteins | |
WO2010129294A3 (en) | Small molecules supporting pluripotent cell growth and methods thereof | |
PH12014501429A1 (en) | Differentiation of human embryonic stem cells into single hormonal insulin positive cells | |
SG196784A1 (en) | Stem cell cultures | |
HK1156976A1 (en) | Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations | |
WO2012135621A3 (en) | Priming of pluripotent stem cells for neural differentiation | |
WO2006050330A3 (en) | Platelets from stem cells | |
WO2010149597A3 (en) | 3D CULTURING SYSTEMS FOR GROWTH AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM (hPS) CELLS | |
MY161726A (en) | Biological methods for preparing adipic acid | |
NZ592622A (en) | Stem cell aggregate suspension compositions and methods for differentiation thereof | |
MX340952B (es) | Diferenciacion de celulas madre embrionarias humanas. | |
MY181513A (en) | Cell culture compositions and methods for polypeptide production | |
BR112012021267A2 (pt) | métodos para a preparação de melanócitos a partir de células tronco humanas pluripotentes. | |
WO2010056808A3 (en) | Compositions and methods for re-programming and re-differentiating cells | |
MX2013002405A (es) | Diferenciacion de celulas madre embrionarias humanas. | |
TW200736399A (en) | Expansion and differentiation of neural stem cells under low oxygen conditions | |
MY184796A (en) | Method for manufacturing ciliary marginal zone-like structure | |
MX2012001004A (es) | Proceso para la obtencion de miofibroblastos. | |
GB2453074A (en) | Differentiation of primate pluripotent cells to hepatocyte-lineage cells | |
EP2582792A4 (en) | HEART OF CARDIOMYOCYTES WITH DIALYSATED SERUM | |
WO2014113704A3 (en) | Enhanced differentiation of mesenchymal stem cells | |
EP3666900A3 (en) | Cell-based production of nonulosonates | |
WO2013184193A3 (en) | Cancer stem cells and methods of using the same | |
PT2573167T (pt) | Processo para a produção de emplastros ou curativos de pele autóloga através de cultivo de queratinócitos e fibroblastos autólogos com soro autólogo para a geração de pele |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |